Showing results (81-90 of 198) with videos related to
Sort By:
Pageof 20
Pediatric Hematology and Oncology|December 13, 2018
Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastomaKevin Bielamowicz, M Fatih Okcu, Rona Sonabend, et al.Cancer Chemotherapy and Pharmacology|November 30, 2018
A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicitiesJennifer H Foster, Patrick A Thompson, M Brooke Bernhardt, et al.Oncogene|October 26, 2002
Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growthYongmin Liu, John Ludes-Meyers, Yun Zhang, et al.Journal of the National Cancer Institute|March 6, 2003
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancerC Kent Osborne, Valerie Bardou, Torsten A Hopp, et al.Cancer Research|November 20, 2002
The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic miceKendall Wu, Yun Zhang, Xiao-Chun Xu, et al.Cancer Research|December 21, 2006
Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arraysHee-Tae Kim, Gu Kong, David Denardo, et al.Cancer Research|May 2, 2013
Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8Zachary C Hartman, Graham M Poage, Petra den Hollander, et al.Breast Cancer Research and Treatment|September 28, 2012
Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrenceCarolyn L Smith, Ilenia Migliaccio, Vaishali Chaubal, et al.Journal of the National Cancer Institute|March 31, 2011
Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor αInes Barone, Lauren Brusco, Guowei Gu, et al.Cancer Research|February 3, 2016
HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated GenesBryan C Nikolai, Rainer B Lanz, Brian York, et al.Pageof 20